Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/2010
04/13/2010CA2407683C Topical anesthetic/opioid formulations and uses thereof
04/13/2010CA2399208C Nucleoside analogs with carboxamidine modified monocyclic base
04/13/2010CA2394165C Drospirenone for hormone replacement therapy
04/13/2010CA2392016C Enantiomeric compounds for treatment of cardiac arrhythmias and methods of use
04/13/2010CA2383372C Cell-specific and/or tumor-specific promoter retargeting of herpes gamma 34.5 gene expression
04/13/2010CA2380805C Improved topical medicaments and methods for photodynamic treatment of disease
04/13/2010CA2379626C Antibacterial composition
04/13/2010CA2373634C Isophosphoramide mustard analogs and use thereof
04/13/2010CA2360680C Antioxidant compositions and methods for companion animals
04/13/2010CA2345809C 6-substituted pyrazolo[3,4-d]pyrimidin-4-ones useful as cyclin dependent kinase inhibitors
04/13/2010CA2336807C Sulfur substituted sulfonylaminocarboxylic acid n-arylamides, their preparation, their use and pharmaceutical preparations comprising them
04/13/2010CA2330206C Poly(adp-ribose) polymerase gene
04/13/2010CA2295678C Pyridine derivatives
04/13/2010CA2293484C Dispenser with doses counter
04/13/2010CA2265500C Novel semaphorin gene: semaphorin y
04/13/2010CA2263675C Compositions comprising an inducing agent and an anti-viral agent for the treatment of blood, viral and cellular disorders
04/13/2010CA2244946C Gene expression vectors which generate an antigen specific immune response and methods of using the same
04/13/2010CA2224217C Pharmaceutically active carotenoids
04/13/2010CA2153593C Compositions and methods for delivery of genetic material
04/13/2010CA2144056C Cd27 ligand
04/13/2010CA2102112C A substance for lowering high cholesterol level in serum and a method for preparing the same
04/09/2010CA2737349A1 Indazole derivatives
04/09/2010CA2682086A1 Micronized composition of a 2,4-disubstituted phenol derivative
04/08/2010WO2010040110A1 Methods and compositions for treatment of acute heart failure
04/08/2010WO2010040091A1 Novel dna nanostructures that promote cell-cell interaction and use thereof
04/08/2010WO2010040063A1 Treatment of hepatitis c infection with metalloporphyrins
04/08/2010WO2010040059A1 Nicotine-based compounds useful for asymmetric synthesis
04/08/2010WO2010040056A1 Synthesis of decitabine
04/08/2010WO2010040055A2 Oral pharmaceutical formulations for antidiabetic compounds
04/08/2010WO2010040020A1 Methods of treating hepatic encephalopathy
04/08/2010WO2010040012A1 Compositions and methods for reducing triglyceride levels
04/08/2010WO2010039997A2 Hematopoietic protection against chemotherapeutic compounds using selective cyclin-dependent kinase 4/6 inhibitors
04/08/2010WO2010039982A1 Crth2 modulators
04/08/2010WO2010039977A2 Heteroaryl antagonists of prostaglandin d2 receptors
04/08/2010WO2010039957A1 Tryptophan hydroxylase inhibitors and methods of their use
04/08/2010WO2010039947A1 Novel compounds as calcium channel blockers
04/08/2010WO2010039939A1 Janus kinase inhibitors for treatment of dry eye and other eye related diseases
04/08/2010WO2010039922A1 Calcilytic compounds
04/08/2010WO2010039920A2 Boldine compounds for promoting bone growth
04/08/2010WO2010039913A1 Calcilytic compounds
04/08/2010WO2010039892A1 Systemic treatment of blood-sucking and blood-consuming parasites oral administration of a parasiticidal agent
04/08/2010WO2010039885A2 Crystalline forms of dexlansoprazole
04/08/2010WO2010039861A2 Dendrimer conjugates
04/08/2010WO2010039851A1 Peripheral opioid receptor antagonists and uses thereof
04/08/2010WO2010039827A2 Treatment of skin and mucosal superficial wounds using adrenergic receptor agonists
04/08/2010WO2010039825A2 IMIDAZO[1,2-a]PYRIDINE COMPOUNDS AS RECEPTOR TYROSINE KINASE INHIBITORS
04/08/2010WO2010039821A1 Implantable device for the delivery of naltrexone and methods of use thereof
04/08/2010WO2010039798A2 Amorphous compositions of sunitinib base and l-malic acid
04/08/2010WO2010039793A1 Hepatitis c virus inhibitors
04/08/2010WO2010039789A1 Spiro-imidazolone derivatives as glucagon receptor antagonists
04/08/2010WO2010039762A2 Pharmaceutical compositions comprising boronic acid compounds
04/08/2010WO2010039740A1 PYRIDOPYRIMIDINONE INHIBITORS OF PI3Kα AND MTOR
04/08/2010WO2010039722A1 Implantable device for the delivery of risperidone and methods of use thereof
04/08/2010WO2010039719A1 Crystalline form of an alkoxyimidazol-1-ylmethyl biphenyl carboxylic acid
04/08/2010WO2010039697A2 Selective inhibition of histone deacetylases 1 and 2 as a treatment for cardiac hypertrophy
04/08/2010WO2010039673A1 Cgrp receptor antagonists
04/08/2010WO2010039668A2 Inhibitors of cyclin kinase inhibitor p21
04/08/2010WO2010039654A2 Topical treatment of skin infection
04/08/2010WO2010039647A2 Selective inhibitors of c-jun n-terminal kinases
04/08/2010WO2010039560A2 Active agent loaded uniform, rigid, spherical, nanoporous calcium phosphate particles and methods of making and using the same
04/08/2010WO2010039545A2 1,2-benzisothiazolinone and isoindolinone derivatives
04/08/2010WO2010039538A2 Flavivirus inhibitors and methods for their use
04/08/2010WO2010039536A2 Sirt4 and uses thereof
04/08/2010WO2010039534A2 Viral and fungal inhibitors
04/08/2010WO2010039518A2 Tricyclic carbamate jak inhibitors
04/08/2010WO2010039490A2 Composition and method for preparing stable unilamellar liposomal suspension
04/08/2010WO2010039474A1 Prodrugs of oxazolidinone cetp inhibitors
04/08/2010WO2010039429A1 Guanylhydrazones for treatment of postoperative intestinal inflammation
04/08/2010WO2010039381A1 Transdermal extended-delivery donepezil compositions and methods for using the same
04/08/2010WO2010039289A2 Compounds and compositions for treating chemical warfare agent-induced injuries
04/08/2010WO2010039260A2 Spiperone derivatives and methods of treating disorders
04/08/2010WO2010039256A1 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
04/08/2010WO2010039251A1 Stabilized composition for treating psoriasis
04/08/2010WO2010039238A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039237A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039236A1 Compounds for inflammation and immune-related uses
04/08/2010WO2010039187A2 Fused diimidazodiazepine compounds and methods of use and manufacture thereof
04/08/2010WO2010039186A2 Compounds useful as faah modulators and uses thereof
04/08/2010WO2010039174A1 Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
04/08/2010WO2010039137A1 Immune regulatory oligonucleotide (iro) compounds to modulate toll-like receptor based immune response
04/08/2010WO2010039124A1 Benzenesulfonic acid salt compounds
04/08/2010WO2010039088A1 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds
04/08/2010WO2010039079A1 Isoquinolinone derivatives
04/08/2010WO2010039054A1 Antimycotic and prebiotic pharmaceutical composition and a method for treating candidal vaginitis
04/08/2010WO2010039049A1 Method of modifying the immune response
04/08/2010WO2010039040A1 Composition comprising a ppar agonist and a phospholipid component
04/08/2010WO2010039039A1 Oral formulations of gemcitabine derivatives
04/08/2010WO2010039019A1 Composition for promoting control of total and ldl cholesterol and/or weight loss and/or thermogenesis
04/08/2010WO2010038965A2 GCH1-TARGETED si RNA, RECOMBINANT VECTOR CONTAINING si RNA, AND PHARMACEUTICAL COMPOSITION CONTAINING RECOMBINANT VECTOR FOR TREATING AND PREVENTING NEUROPATHIC PAIN
04/08/2010WO2010038948A2 Arylpiperazine-containing pyrrole 3-carboxamide derivatives for treating depressive disorders
04/08/2010WO2010038901A1 7-piperidinoalkyl-3,4-dihydroquinolone derivative
04/08/2010WO2010038895A1 Casr agonist
04/08/2010WO2010038874A1 Anti-xdr-tb agent, anti-mdr-tb agent, and combined anti-tuberculous agent
04/08/2010WO2010038842A1 Novel polyphenol compound
04/08/2010WO2010038803A1 2-indoleacrylamide analogue
04/08/2010WO2010038796A1 Therapeutic agent for hepatitis c
04/08/2010WO2010038771A1 Light-stabilized pharmaceutical composition
04/08/2010WO2010038765A1 Novel type i natural ceramide derivative and method for producing same
04/08/2010WO2010038690A1 Controlled release pharmaceutical composition
04/08/2010WO2010038689A1 Pharmaceutical composition for oral administration
1 ... 2313 2314 2315 2316 2317 2318 2319 2320 2321 2322 2323 2324 2325 2326 2327 2328 2329 2330 2331 2332 2333 ... 7860